Ameriprise’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.5M | Sell |
1,344,460
-146,198
| -10% | -$5.38M | 0.01% | 869 |
|
|
2025
Q1 | $52.7M | Sell |
1,490,658
-136,190
| -8% | -$4.82M | 0.01% | 817 |
|
|
2024
Q4 | $71.2M | Buy |
1,626,848
+141,426
| +10% | +$6.19M | 0.02% | 681 |
|
|
2024
Q3 | $67.4M | Buy |
1,485,422
+13,132
| +0.9% | +$596K | 0.02% | 712 |
|
|
2024
Q2 | $57.1M | Sell |
1,472,290
-222,211
| -13% | -$8.62M | 0.02% | 738 |
|
|
2024
Q1 | $54.6M | Buy |
1,694,501
+71,480
| +4% | +$2.3M | 0.02% | 770 |
|
|
2023
Q4 | $46.5M | Buy |
1,623,021
+411,165
| +34% | +$11.8M | 0.01% | 809 |
|
|
2023
Q3 | $33.5M | Sell |
1,211,856
-11,869
| -1% | -$329K | 0.01% | 933 |
|
|
2023
Q2 | $32.7M | Buy |
1,223,725
+99,767
| +9% | +$2.67M | 0.01% | 971 |
|
|
2023
Q1 | $24.3M | Buy |
1,123,958
+423,035
| +60% | +$9.16M | 0.01% | 1138 |
|
|
2022
Q4 | $16.7M | Sell |
700,923
-292,140
| -29% | -$6.96M | 0.01% | 1327 |
|
|
2022
Q3 | $19.6M | Sell |
993,063
-8,245
| -0.8% | -$162K | 0.01% | 1195 |
|
|
2022
Q2 | $19.5M | Buy |
1,001,308
+30,794
| +3% | +$600K | 0.01% | 1220 |
|
|
2022
Q1 | $24.8M | Buy |
970,514
+9,218
| +1% | +$235K | 0.01% | 1193 |
|
|
2021
Q4 | $24.2M | Buy |
961,296
+2,069
| +0.2% | +$52.1K | 0.01% | 1274 |
|
|
2021
Q3 | $26.4M | Buy |
959,227
+21,742
| +2% | +$598K | 0.01% | 1076 |
|
|
2021
Q2 | $29.7M | Buy |
937,485
+517,478
| +123% | +$16.4M | 0.01% | 1071 |
|
|
2021
Q1 | $19.3M | Buy |
420,007
+148,682
| +55% | +$6.82M | 0.01% | 1355 |
|
|
2020
Q4 | $10.7M | Buy |
271,325
+221,086
| +440% | +$8.75M | ﹤0.01% | 1703 |
|
|
2020
Q3 | $1.75M | Buy |
50,239
+5,795
| +13% | +$202K | ﹤0.01% | 2735 |
|
|
2020
Q2 | $1.4M | Sell |
44,444
-19,091
| -30% | -$603K | ﹤0.01% | 2768 |
|
|
2020
Q1 | $1.39M | Buy |
+63,535
| New | +$1.39M | ﹤0.01% | 2668 |
|